Favourable outcomes of repeat one-stage exchange for periprosthetic joint infection of the hip.

Liechti, Emanuel F; Neufeld, Michael E; Soto, Fernando; Linke, Philip; Busch, Sophia-Marlene; Gehrke, Thorsten; Citak, Mustafa (2022). Favourable outcomes of repeat one-stage exchange for periprosthetic joint infection of the hip. The Bone & Joint Journal, 104-B(1), pp. 27-33. British Editorial Society of Bone and Joint Surgery 10.1302/0301-620X.104B1.BJJ-2021-0970.R1

[img] Text
0301-620x.104b1.bjj-2021-0970.r1.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (496kB)

AIMS

One-stage exchange for periprosthetic joint infection (PJI) in total hip arthroplasty (THA) is gaining popularity. The outcome for a repeat one-stage revision THA after a failed one-stage exchange for infection remains unknown. The aim of this study was to report the infection-free and all-cause revision-free survival of repeat one-stage exchange, and to investigate the association between the Musculoskeletal Infection Society (MSIS) staging system and further infection-related failure.

METHODS

We retrospectively reviewed all repeat one-stage revision THAs performed after failed one-stage exchange THA for infection between January 2008 and December 2016. The final cohort included 32 patients. The mean follow-up after repeat one-stage exchange was 5.3 years (1.2 to 13.0). The patients with a further infection-related failure and/or all-cause revision were reported, and Kaplan-Meier survival for these endpoints determined. Patients were categorized according to the MSIS system, and its association with further infection was analyzed.

RESULTS

A total of eight repeat septic revisions (25%) developed a further infection-related failure, and the five-year infection-free survival was 81% (95% confidence interval (CI) 57 to 92). Nine (28%) underwent a further all-cause revision and the five-year all-cause revision-free survival was 74% (95% CI 52 to 88). Neither the MSIS classification of the host status (p = 0.423) nor the limb status (p = 0.366) was significantly associated with further infection-related failure.

CONCLUSION

Repeat one-stage exchange for PJI in THA is associated with a favourable five-year infection-free and all-cause revision-free survival. Notably, the rate of infection control is encouraging when compared with the reported rates after repeat two-stage exchange. The results can be used to counsel patients and help clinicians make informed decisions about treatment. With the available number of patients, further infection-related failure was not associated with the MSIS host or limb status. Cite this article: Bone Joint J 2022;104-B(1):27-33.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Orthopaedic Surgery

UniBE Contributor:

Liechti, Emanuel

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2049-4394

Publisher:

British Editorial Society of Bone and Joint Surgery

Language:

English

Submitter:

Kathrin Aeschlimann

Date Deposited:

25 Jan 2022 16:49

Last Modified:

05 Dec 2022 16:02

Publisher DOI:

10.1302/0301-620X.104B1.BJJ-2021-0970.R1

PubMed ID:

34969284

Uncontrolled Keywords:

Failure Musculoskeletal Infection Musculoskeletal Infection Society (MSIS) staging system One-stage exchange arthroplasty Outcomes Periprosthetic joint infection (PJI) Repeat Revision total hip arthroplasty Survival antibiotics clinicians debridement debridement, antibiotics, and implant retention hips infections organism(s) total hip arthroplasty (THA)

BORIS DOI:

10.48350/164036

URI:

https://boris.unibe.ch/id/eprint/164036

Actions (login required)

Edit item Edit item
Provide Feedback